
Join the All of Us Research Program...
The All of Us research program, part of the Precision Medicine Initiative through the National Institutes of Health (NIH), is an...
This study is designed to investigate the safety and efficacy of Nab®-Paclitaxel (ABRAXANE®) in combination with Carboplatin as first line treatment.
Contact Candace LeBlanc 508-556-5431 or Marcy Kirkpatrick 508-556-5429 for more information.
For more information about this study:
https://clinicaltrials.gov/ct2/show/NCT02151149